modeling barth syndrome using patient-specific, ipsc-derived cardiomyocytes
Published 11 years ago • 515 plays • Length 32:54Download video MP4
Download video MP3
Similar videos
-
32:30
modeling the mitochondrial myopathy of barth syndrome using ipsc and heart-on-chip technologies
-
40:14
using patient specific ipsc-cardiomyocytes for disease modeling
-
21:32
megan mccain: modeling barth syndrome-associated cardiomyopathy
-
51:40
heart disease in a dish: human ipsc-derived multicellular cardiac organoids
-
1:05:33
diabetic cardiomyopathy modeling & screening with ipsc cardiomyocytes
-
25:05
generation of induced pluripotent stem cell-derived cardiomyocytes for disease modeling
-
49:27
todd j herron - generation of purified human ipsc derived cardiomyocytes...
-
31:31
using ipsc-derived cardiomyocytes to study the genetics of left ventricular hypertrophy
-
59:40
human ipsc-based disease modeling and therapeutic development
-
23:25
differentiation of human pluripotent stem cells into atrial and ventricular cardiomyocyte subtypes
-
49:19
advances in modeling human diseases using induced pluripotent stem cell-derived cellular models
-
2:01
human ipsc-derived cardiomyocytes, cardiac fibroblasts, & endothelial cells l protocol preview
-
59:47
modeling lipid and glucose metabolism using human ipsc-derived hepatocytes
-
58:43
human ipsc-derived midbrain dopaminergic neurons for parkinson’s disease modeling and cell therapy
-
1:01:00
predictive human induced pluripotent stem cell-derived cardiomyocyte model of cardiotoxicity
-
16:51
using ips cell technology to model human neurodegenerative diseases
-
6:51
massive expansion and biobanking of stem cell derived cardiomyocytes | umc utrecht
-
35:21
sps 2018: implementing human ipsc-derived cells in early safety assessment & disease modeling
-
1:14:03
webinar: using human cardiomyocytes in phenotypic screens and target verification